Morgan Stanley says flu vaccine data is likely to boost Moderna's stock

thumbnail
Jesse Pound@/in/jesse-pound@jesserpound
WATCH LIVE
Jakub Porzycki | NurPhoto | Getty Images

Moderna's vaccine platform may have another success story in the pipeline, according to Morgan Stanley.